title: Treatment of adynamic bone disease in a haemodialysis patient with teriparatide.
abstract: Prevalence of adynamic bone disease (ABD), characterized by low bone turnover and absence or a reduced number of osteoblasts and osteoclasts, is increasing steadily over the last years. We present a dialysis patient, with recurrent bone fractures and biopsy-proven ABD, who was treated with teriparatide. Nine months after initiation of treatment, iPTH plasma levels increased to 520 pg/mL and a second bone biopsy revealed high bone turnover, normal mineralization and normal bone volume. Two years later, iPTH was 250-350 pg/dL and bone metabolism parameters within normal range. The probable utility of teriparatide in the treatment of ABD in dialysis patients is discussed.
authors: Department of Nephrology, Aristotle University of Thessaloniki , Hippokration General Hospital , Thessaloniki , Greece.
authors: Panagiotis
authors: P
authors: Giamalis
authors: Department of Nephrology, Aristotle University of Thessaloniki , Hippokration General Hospital , Thessaloniki , Greece.
authors: Dominiki
authors: D
authors: Economidou
authors: Department of Nephrology, Aristotle University of Thessaloniki , Hippokration General Hospital , Thessaloniki , Greece.
authors: Chrysostomos
authors: C
authors: Dimitriadis
authors: Department of Nephrology, Aristotle University of Thessaloniki , Hippokration General Hospital , Thessaloniki , Greece.
authors: Dimitrios
authors: D
authors: Memmos
authors: Department of Nephrology, Aristotle University of Thessaloniki , Hippokration General Hospital , Thessaloniki , Greece.
authors: Aikaterini
authors: A
authors: Papagianni
authors: Department of Nephrology, Aristotle University of Thessaloniki , Hippokration General Hospital , Thessaloniki , Greece.
authors: Georgios
authors: G
authors: Efstratiadis
keywords: adynamic bone disease; haemodialysis; teriparatide